AMJB buffered equity notes linked to Nasdaq-100 and S&P 500
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC has priced $2,090,000 of Capped Dual Directional Buffered Equity Notes linked to the lesser performer of the Nasdaq-100 Index® and the S&P 500® Index, fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes are scheduled to mature on May 30, 2028, with a 15.00% downside buffer and a Maximum Upside Return of 29.00%, capping the payment at $1,290.00 per $1,000 note when the lesser performing index rises sufficiently.
If the lesser performing index declines by up to 15.00%, investors receive a positive return equal to the absolute decline, up to $1,150.00 per $1,000 note, but losses increase one-for-one beyond that level and can reach 85.00% of principal. The notes pay no interest or dividends, are unsecured obligations subject to the credit risk of both JPMorgan Financial and JPMorgan Chase & Co., and are not listed, so secondary market liquidity may be limited. The estimated value at pricing was $955.20 per $1,000, below the $1,000 price to the public, reflecting selling commissions, hedging costs and issuer funding assumptions.
Positive
- None.
Negative
- None.
FAQ
What are the key terms of JPMorgan AMJB Capped Dual Directional Buffered Equity Notes?
The notes are $2,090,000 in aggregate principal amount, issued in $1,000 denominations, linked to the lesser performer of the Nasdaq-100 Index® and the S&P 500® Index. They have a 15.00% downside buffer, a Maximum Upside Return of 29.00% and are scheduled to mature on May 30, 2028, with an observation date on May 24, 2028.
How do the AMJB notes linked to the Nasdaq-100 and S&P 500 determine the payoff at maturity?
The payment depends on the “Lesser Performing Index Return.” If both indices finish above their initial levels, holders receive $1,000 plus the lesser index return, capped at a 29.00% gain. If both are at or within 15.00% below their initial levels, holders receive $1,000 plus the absolute loss of the lesser index. If either index falls by more than 15.00%, principal is reduced 1% for each 1% loss beyond the 15.00% buffer.
What is the downside risk for investors in the JPMorgan AMJB structured notes?
If the final level of either index is more than 15.00% below its initial level, the notes repay less than principal. In that case, the payoff per $1,000 equals $1,000 plus $1,000 times the sum of the lesser performing index return and the 15.00% buffer, so a 60.00% decline in the lesser index would lead to a 45.00% loss and a $550.00 payment, and a 100.00% loss could reduce the payment to $150.00.
Do the JPMorgan AMJB notes pay interest or provide dividends from the indices?
No. The notes do not pay periodic interest and do not pass through dividends from any securities in the Nasdaq-100 Index® or the S&P 500® Index. Any return is realized only at maturity based on the specified formulas tied to index performance.
What is the estimated value of the AMJB notes compared with the price to the public?
The price to the public is $1,000 per note, while the estimated value at the time terms were set was $955.20 per $1,000 principal amount note. The difference reflects selling commissions, projected hedging profits or losses and the estimated costs of hedging, as well as the issuer’s internal funding rate.
What credit and liquidity risks apply to investors in the JPMorgan AMJB structured notes?
The notes are unsecured, unsubordinated obligations of JPMorgan Chase Financial Company LLC, fully and unconditionally guaranteed by JPMorgan Chase & Co., so payments depend on the credit of both entities. The notes are not listed on any exchange, and any secondary trading price will be determined by J.P. Morgan Securities LLC and may be lower than the original issue price.
How are the AMJB notes expected to be treated for U.S. federal income tax purposes?
Based on current conditions, special tax counsel believes it is reasonable to treat the notes as “open transactions” that are not debt instruments, so gain or loss should generally be capital gain or loss, long-term if held more than one year. The discussion notes that IRS guidance or future regulations could change this treatment.